Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • The usefulness of progression-...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

The usefulness of progression-free survival in surgical treatment of lung metastases

Bibliographic Details
Published in:Polish Journal of Thoracic and Cardiovascular Surgery
Main Authors: Jarosław Religioni, Daniel Rabczenko, Tadeusz Orłowski
Format: Article
Language:English
Published: Termedia Publishing House 2022-06-01
Subjects:
lung metastases
surgical treatment
progression-free survival
overall survival.
Online Access:https://www.termedia.pl/The-usefulness-of-progression-free-survival-in-surgical-r-ntreatment-of-lung-metastases,40,47310,1,1.html
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.termedia.pl/The-usefulness-of-progression-free-survival-in-surgical-r-ntreatment-of-lung-metastases,40,47310,1,1.html

Similar Items

  • Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer
    by: Masayuki Aboshi, et al.
    Published: (2014-02-01)
  • Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study
    by: Xiaoshi Zhang, et al.
    Published: (2024-04-01)
  • Nomograms integrating CT radiomic and deep learning signatures to predict overall survival and progression-free survival in NSCLC patients treated with chemotherapy
    by: Runsheng Chang, et al.
    Published: (2023-10-01)
  • Sarcopenia as a risk factor of progression-free survival in patients with metastases: a systematic review and meta-analysis
    by: Lingli Luo, et al.
    Published: (2023-02-01)
  • Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis
    by: Zhensheng Li, et al.
    Published: (2019-11-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs